Conduit Pharmaceuticals Inc (NASDAQ: CDT) is 34.11% higher on its value in year-to-date trading and has touched a low of $0.05 and a high of $4.09 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CDT stock was last observed hovering at around $0.09 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.09, the stock is 20.58% and 4.16% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 24.99 million and changing -1.29% at the moment leaves the stock -90.73% off its SMA200. CDT registered -97.95% loss for a year compared to 6-month loss of -61.67%. The firm has a 50-day simple moving average (SMA 50) of $0.08852 and a 200-day simple moving average (SMA200) of $1.009445.
The stock witnessed a 4.19% gain in the last 1 month and extending the period to 3 months gives it a -20.96%, and is 27.25% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 47.78% over the week and 25.40% over the month.
Conduit Pharmaceuticals Inc (CDT) has around 7 employees, a market worth around $11.03M and $0.00M in sales. Distance from 52-week low is 80.39% and -97.75% from its 52-week high.
.
Conduit Pharmaceuticals Inc (CDT) Top Institutional Holders
52.0 institutions hold shares in Conduit Pharmaceuticals Inc (CDT), with institutional investors hold 7.97% of the company’s shares. The shares outstanding are 96.00M, and float is at 72.97M with Short Float at 5.13%. Institutions hold 4.06% of the Float.
Conduit Pharmaceuticals Inc (CDT) Insider Activity
The most recent transaction is an insider sale by Nirland Ltd, the company’s 10% Owner. SEC filings show that Nirland Ltd sold 1,500,000 shares of the company’s common stock on Oct 03 ’24 at a price of $0.10 per share for a total of $0.16 million. Following the sale, the insider now owns 8.4 million shares.
Conduit Pharmaceuticals Inc disclosed in a document filed with the SEC on Oct 04 ’24 that Nirland Ltd (10% Owner) sold a total of 1,368,991 shares of the company’s common stock. The trade occurred on Oct 04 ’24 and was made at $0.10 per share for $0.14 million. Following the transaction, the insider now directly holds 7.03 million shares of the CDT stock.
Still, SEC filings show that on Oct 07 ’24, Nirland Ltd (10% Owner) disposed off 939,009 shares at an average price of $0.10 for $96530.0. The insider now directly holds 6,092,000 shares of Conduit Pharmaceuticals Inc (CDT).
